IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%

MT Newswires

06/16

IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the Singapore Exchange.

Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.

The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.

The move also comes after the company secured a $41 million US Department of Defense contract.

The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2643735919"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2643735919\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2643735919?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-16 12:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2643735919","market":"sg","top_or_hot":-1,"title":"IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%","media":"MT Newswires","content":"<html><body><p> IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the <a href=\"https://laohu8.com/S/S68.SI\">Singapore Exchange</a>.</p><p>Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.</p><p>The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.</p><p>The move also comes after the company secured a $41 million US Department of Defense contract.</p><p>The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIX Biopharma to Relocate Manufacturing Equipment to US; Shares Fall 8%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1060499803\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires </p>\n<p class=\"h-time\">2026-06-16 12:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the <a href=\"https://laohu8.com/S/S68.SI\">Singapore Exchange</a>.</p><p>Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.</p><p>The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.</p><p>The move also comes after the company secured a $41 million US Department of Defense contract.</p><p>The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6506","symbol_name":"制药与医学研究概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2643735919","we_media_id":"1060499803","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2643735919","pubTimestamp":1781584977,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"MT Newswires","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1060499803","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"IX Biopharma  will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the Singapore Exchange.Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.The move also comes after the company secured a $41 million US Department of Defense contract.The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6506":"制药与医学研究概念","BK6079":"制药","42C.SI":"IX生物制药"},"translate_title":"IX Biopharma将生产设备迁至美国；股价下跌8%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"42C.SI":0.9},"content_text":"IX Biopharma (SGX:42C) will relocate its manufacturing equipment from its facility in Australia to a 503B-licensed plant in Nevada, U.S., according to a Monday filing with the Singapore Exchange.Shares of the healthcare services company were down over 8% in Tuesday's late-morning trading.The plant is managed by the company's joint venture partner, Orion Specialty Labs, and the relocation is expected to be completed in the third quarter of the year.The move also comes after the company secured a $41 million US Department of Defense contract.The relocation comes in the wake of the US unveiling tariffs of up to 100% on pharmaceutical imports from Australia.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}